(CRM) Salesforce.com - Overview

Sector: Technology | Industry: Software - Application | Exchange: NYSE (USA) | Market Cap: 174.507m USD | Total Return: -26.2% in 12m

Stock CRM, Platform, Analytics, Commerce, Service
Total Rating 52
Safety 76
Buy Signal -0.23
Market Cap: 174,507m
Avg Trading Vol: 2.25B USD
ATR: 4.27%
Peers RS (IBD): 47.3
Risk 5d forecast
Volatility36.4%
Rel. Tail Risk-10.5%
Reward TTM
Sharpe Ratio-0.95
Alpha-50.44
Character TTM
Beta1.117
Beta Downside0.978
Drawdowns 3y
Max DD51.20%
CAGR/Max DD-0.03
EPS (Earnings per Share) EPS (Earnings per Share) of CRM over the last years for every Quarter: "2021-04": 1.21, "2021-07": 1.48, "2021-10": 1.27, "2022-01": 0.84, "2022-04": 0.98, "2022-07": 1.19, "2022-10": 1.4, "2023-01": 1.68, "2023-04": 1.69, "2023-07": 2.12, "2023-10": 2.11, "2024-01": 2.29, "2024-04": 2.44, "2024-07": 2.56, "2024-10": 2.41, "2025-01": 2.78, "2025-04": 2.58, "2025-07": 1.96, "2025-10": 3.25, "2026-01": 3.81,
EPS CAGR: 43.63%
EPS Trend: 89.5%
Last SUE: 4.00
Qual. Beats: 3
Revenue Revenue of CRM over the last years for every Quarter: 2021-04: 5963, 2021-07: 6340, 2021-10: 6863, 2022-01: 7326, 2022-04: 7411, 2022-07: 7720, 2022-10: 7837, 2023-01: 8384, 2023-04: 8247, 2023-07: 8603, 2023-10: 8720, 2024-01: 9287, 2024-04: 9133, 2024-07: 9325, 2024-10: 9444, 2025-01: 9993, 2025-04: 9829, 2025-07: 10236, 2025-10: 10259, 2026-01: 11201,
Rev. CAGR: 11.64%
Rev. Trend: 98.4%
Last SUE: 0.56
Qual. Beats: 0
Description: CRM Salesforce.com

Salesforce (NYSE: CRM) delivers a comprehensive suite of cloud-based CRM solutions, ranging from the Agentforce AI layer and Data Cloud engine to Slack, Tableau, and industry-specific AI agents. Its portfolio also includes Salesforce Starter for SMBs, commerce services, and field-service tools that unify sales, service, and marketing workflows on a single platform.

In FY 2025 the company posted $31.4 billion in revenue, a 12% year-over-year increase, with subscription-and-support revenue reaching $27.1 billion and operating cash flow of $6.2 billion. Adoption of its Data Cloud and AI-driven features grew roughly 45% YoY, reflecting broader enterprise spending on AI-enabled software, which the IDC forecasts will expand at a 9% annual rate through 2027.

For a deeper dive, you might explore ValueRay’s analyst notes on CRM.

Headlines to Watch Out For
  • Cloud software demand drives subscription revenue growth
  • AI integration expands platform capabilities and market share
  • Enterprise spending trends impact new license sales
  • Competition from Microsoft and Oracle pressures pricing
  • Economic slowdowns reduce customer acquisition and expansion
Piotroski VR‑10 (Strict) 8.0
Net Income: 7.46b TTM > 0 and > 6% of Revenue
FCF/TA: 0.13 > 0.02 and ΔFCF/TA 0.74 > 1.0
NWC/Revenue: -21.42% < 20% (prev 4.61%; Δ -26.03% < -1%)
CFO/TA 0.13 > 3% & CFO 15.00b > Net Income 7.46b
Net Debt (9.85b) to EBITDA (12.72b): 0.77 < 3
Current Ratio: 0.76 > 1.5 & < 3
Outstanding Shares: last quarter (940.0m) vs 12m ago -3.49% < -2%
Gross Margin: 77.68% > 18% (prev 0.77%; Δ 7.69k% > 0.5%)
Asset Turnover: 38.59% > 50% (prev 36.82%; Δ 1.77% > 0%)
Interest Coverage Ratio: 45.02 > 6 (EBITDA TTM 12.72b / Interest Expense TTM 202.0m)
Altman Z'' 1.14
A: -0.08 (Total Current Assets 28.22b - Total Current Liabilities 37.12b) / Total Assets 112.31b
B: 0.20 (Retained Earnings 22.22b / Total Assets 112.31b)
C: 0.08 (EBIT TTM 9.09b / Avg Total Assets 107.62b)
D: 0.42 (Book Value of Equity 22.54b / Total Liabilities 53.16b)
Altman-Z'' Score: 1.14 = BB
Beneish M -2.91
DSRI: 1.10 (Receivables 14.34b/11.95b, Revenue 41.52b/37.90b)
GMI: 0.99 (GM 77.68% / 77.19%)
AQI: 1.07 (AQ_t 0.70 / AQ_t-1 0.66)
SGI: 1.10 (Revenue 41.52b / 37.90b)
TATA: -0.07 (NI 7.46b - CFO 15.00b) / TA 112.31b)
Beneish M-Score: -2.91 (Cap -4..+1) = A
What is the price of CRM shares? As of April 05, 2026, the stock is trading at USD 186.67 with a total of 10,905,293 shares traded.
Over the past week, the price has changed by +4.39%, over one month by -4.52%, over three months by -26.96% and over the past year by -26.18%.
Is CRM a buy, sell or hold? Salesforce.com has received a consensus analysts rating of 4.22. Therefore, it is recommended to buy CRM.
  • StrongBuy: 28
  • Buy: 13
  • Hold: 12
  • Sell: 2
  • StrongSell: 0
What are the forecasts/targets for the CRM price?
Wallstreet Target Price 273.1 46.3%
Analysts Target Price 273.1 46.3%
CRM Fundamental Data Overview as of 03 April 2026
P/E Trailing = 23.8769
P/E Forward = 14.1443
P/S = 4.2025
P/B = 2.9066
P/EG = 1.0105
Revenue TTM = 41.52b USD
EBIT TTM = 9.09b USD
EBITDA TTM = 12.72b USD
Long Term Debt = 10.44b USD (from longTermDebt, last quarter)
Short Term Debt = 4.55b USD (from shortTermDebt, last quarter)
Debt = 17.18b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.85b USD (from netDebt column, last quarter)
Enterprise Value = 182.12b USD (174.51b + Debt 17.18b - CCE 9.56b)
Interest Coverage Ratio = 45.02 (Ebit TTM 9.09b / Interest Expense TTM 202.0m)
EV/FCF = 12.65x (Enterprise Value 182.12b / FCF TTM 14.40b)
FCF Yield = 7.91% (FCF TTM 14.40b / Enterprise Value 182.12b)
FCF Margin = 34.68% (FCF TTM 14.40b / Revenue TTM 41.52b)
Net Margin = 17.96% (Net Income TTM 7.46b / Revenue TTM 41.52b)
Gross Margin = 77.68% ((Revenue TTM 41.52b - Cost of Revenue TTM 9.27b) / Revenue TTM)
Gross Margin QoQ = 77.61% (prev 78.02%)
Tobins Q-Ratio = 1.62 (Enterprise Value 182.12b / Total Assets 112.31b)
Interest Expense / Debt = 0.39% (Interest Expense 67.0m / Debt 17.18b)
Taxrate = 26.07% (685.0m / 2.63b)
NOPAT = 6.72b (EBIT 9.09b * (1 - 26.07%))
Current Ratio = 0.76 (Total Current Assets 28.22b / Total Current Liabilities 37.12b)
Debt / Equity = 0.29 (Debt 17.18b / totalStockholderEquity, last quarter 59.14b)
Debt / EBITDA = 0.77 (Net Debt 9.85b / EBITDA 12.72b)
Debt / FCF = 0.68 (Net Debt 9.85b / FCF TTM 14.40b)
Total Stockholder Equity = 60.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.93% (Net Income 7.46b / Total Assets 112.31b)
RoE = 12.37% (Net Income TTM 7.46b / Total Stockholder Equity 60.29b)
RoCE = 12.86% (EBIT 9.09b / Capital Employed (Equity 60.29b + L.T.Debt 10.44b))
RoIC = 9.57% (NOPAT 6.72b / Invested Capital 70.23b)
WACC = 9.05% (E(174.51b)/V(191.68b) * Re(9.91%) + D(17.18b)/V(191.68b) * Rd(0.39%) * (1-Tc(0.26)))
Discount Rate = 9.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.81%
[DCF] Terminal Value 78.25% ; FCFF base≈13.61b ; Y1≈16.80b ; Y5≈28.66b
[DCF] Fair Price = 427.6 (EV 404.48b - Net Debt 9.85b = Equity 394.64b / Shares 923.0m; r=9.05% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 89.47 | EPS CAGR: 43.63% | SUE: 4.0 | # QB: 3
Revenue Correlation: 98.37 | Revenue CAGR: 11.64% | SUE: 0.56 | # QB: 0
EPS next Quarter (2026-07-31): EPS=3.24 | Chg7d=+0.003 | Chg30d=+0.004 | Revisions Net=+0 | Analysts=39
EPS current Year (2027-01-31): EPS=13.20 | Chg7d=+0.008 | Chg30d=+0.038 | Revisions Net=-1 | Growth EPS=+5.4% | Growth Revenue=+11.1%
EPS next Year (2028-01-31): EPS=14.89 | Chg7d=-0.018 | Chg30d=+0.021 | Revisions Net=+0 | Growth EPS=+12.8% | Growth Revenue=+9.5%
[Analyst] Revisions Ratio: +0.00 (19 Up / 19 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.7% (Discount Rate 9.9% - Earnings Yield 4.2%)
[Growth] Growth Spread = +5.1% (Analyst 10.8% - Implied 5.7%)
External Resources